Search Results - "Liefers, G.J."

Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges by Heil, J., Kuerer, H.M., Pfob, A., Rauch, G., Sinn, H.P., Golatta, M., Liefers, G.J., Vrancken Peeters, M.J.

“…In patients with operable early breast cancer, neoadjuvant systemic treatment (NST) is a standard approach. Indications have expanded from downstaging of…”
Get full text

Prevention of seroma formation after axillary dissection in breast cancer: A systematic review by van Bemmel, A.J.M, van de Velde, C.J.H, Schmitz, R.F, Liefers, G.J

“…Abstract Background The most common complication after breast cancer surgery is seroma formation. It is a source of significant morbidity and discomfort. Many…”
Get full text

Colorectal cancer screening: systematic review of screen-related morbidity and mortality by Vermeer, N.C.A, Snijders, H.S, Holman, F.A, Liefers, G.J, Bastiaannet, E, van de Velde, C.J.H, Peeters, K.C.M.J

“…Highlights • This systematic review is limited to participants with average cancer risk. • Colonoscopy as colorectal cancer screening modality has low…”
Get full text

Cause of death the first year after curative colorectal cancer surgery; a prolonged impact of the surgery in elderly colorectal cancer patients by Dekker, J.W.T, Gooiker, G.A, Bastiaannet, E, van den Broek, C.B.M, van der Geest, L.G.M, van de Velde, C.J, Tollenaar, R.A.E.M, Liefers, G.J

“…Abstract Background The 1-year mortality after colorectal cancer surgery is high and explains age related differences in colorectal cancer survival. To gain…”
Get full text

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials by Kroep, J.R, Charehbili, A, Coleman, R.E, Aft, R.L, Hasegawa, Y, Winter, M.C, Weilbaecher, K, Akazawa, K, Hinsley, S, Putter, H, Liefers, G.J, Nortier, J.W.R, Kohno, N

“…Abstract Purpose The addition of bisphosphonates to adjuvant therapy improves survival in postmenopausal breast cancer (BC) patients. We report a meta-analysis…”
Get full text

Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis by Kiderlen, M., de Glas, N.A., Bastiaannet, E., Engels, C.C., van de Water, W., de Craen, A.J.M., Portielje, J.E.A., van de Velde, C.J.H., Liefers, G.J.

“…In developed countries, 40% of breast cancer patients are >65 years of age at diagnosis, of whom 16% additionally suffer from diabetes. The aim of this study…”
Get full text

Adjuvant chemotherapy and relative survival of patients with stage II colon cancer – A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania by Breugom, A.J, Bastiaannet, E, Boelens, P.G, Iversen, L.H, Martling, A, Johansson, R, Evans, T, Lawton, S, O'Brien, K.M, Van Eycken, E, Janciauskiene, R, Liefers, G.J, Cervantes, A, Lemmens, V.E.P.P, van de Velde, C.J.H

“…Abstract Background The aim of the present EURECCA international comparison is to compare adjuvant chemotherapy and relative survival of patients with stage II…”
Get full text

Surgery in metastatic breast cancer: Patients with a favorable profile seem to have the most benefit from surgery by Rashaan, Z.M, Bastiaannet, E, Portielje, J.E.A, van de Water, W, van der Velde, S, Ernst, M.F, van de Velde, C.J.H, Liefers, G.J

“…Abstract Introduction About 3–10% of breast cancer patients have distant metastases (Stage IV) at initial presentation; standard treatment (in the Netherlands)…”
Get full text

Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review by Charehbili, A, Fontein, D.B.Y, Kroep, J.R, Liefers, G.J, Mieog, J.S.D, Nortier, J.W.R, van de Velde, C.J.H

“…Abstract In recent years, studies investigating neoadjuvant therapies have been emerging, because of the additional benefits it provides in terms of…”
Get full text

2121 Comparing treatment strategies and relative survival between the Netherlands and Belgium for patients aged 75 years and older with stage I-III rectal cancer by Breuqom, A.J, Bastiaannet, E, Boelens, P.G, Van Eycken, E, Vandendael, T, Liefers, G.J, Rutten, H.J.T, Lemmens, V.E, Velde, C.J.H. Van de

Get full text

2306 Aspirin and gastro intestinal malignancies; improved survival not only in colorectal cancer? by Frouws, M, Bastiaannet, E, Van Herk-Sukel, M, Putter, H, Portielje, J, Van De Velde, C, Liefers, G.J

Get full text

Age and the effect of physical activity on breast cancer survival: A systematic review by Fontein, D.B.Y, de Glas, N.A, Duijm, M, Bastiaannet, E, Portielje, J.E.A, Van de Velde, C.J.H, Liefers, G.J

“…Summary The effect of physical activity (PA) on cancer survival is still the topic of debate in oncology research focusing on survivorship, and has been…”
Get full text

The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer by Frouws, M.A, Rademaker, E, Bastiaannet, E, van Herk-Sukel, M.P.P, Lemmens, V.E, Van de Velde, C.J.H, Portielje, J.E.A, Liefers, G.J

“…Abstract Background Several studies have suggested that the association between aspirin and improved cancer survival is mediated through the mechanism of…”
Get full text

Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006–05) by Van de Velde, C.J.H, Blok, E, Meershoek-Klein Kranenbarg, E, Putter, H, Van den Bosch, J, Maartense, E, Duijm-de Carpentier, M, Van Leeuwen-Stok, E, Liefers, G.J, Nortier, J, Rutgers, E, Kroep, J

Get full text

56. The effect of thrombocyte aggregation inhibitors on cancer survival: More evidence for a platelet-mediated effect of aspirin on cancer by Frouws, M, Rademaker, E, Bastiaannet, E, Van Herk-Sukel, M, Lemmens, V, Van de Velde, C, Portielje, J, Liefers, G.J

Get full text

Survival of older patients with metastasised breast cancer lags behind despite evolving treatment strategies – A population-based study by de Glas, N.A, Bastiaannet, E, de Craen, A.J.M, van de Velde, C.J.H, Siesling, S, Liefers, G.J, Portielje, J.E.A

“…Abstract Background Older women are more likely to be diagnosed with primary metastasised breast cancer than their younger counterparts. Evolving treatment…”
Get full text

1323 Differences in proportion adjuvant chemotherapy are not associated with relative survival for stage II colon cancer patients aged 75 years and older - a EURECCA international comparison by Breugom, A.J, Bastiaannet, E, Boelens, P.G, Van Eycken, E, Vandendael, T, Iversen, L.H, O'Brien, K, Martling, A, Pahlman, L, Liefers, G.J, Rutten, H.J.T, Lemmens, V.E, Van de Velde, C.J.H

Get full text

1306 Management of early stage breast cancer in older patients - An international comparison of standard care versus oncogeriatric care by Kiderlen, M, Bastiaannet, E, Egan, K, Van de Water, W, De Craen, A, Balducci, L, Van de Velde, C, Liefers, G.J, Extermann, M

Get full text

1311 Physical functioning in older patients with breast cancer: A TEAM lifestyle analysis by Derks, M, De Glas, N, Bastiaannet, E, De Craen, A, Portielje, J, Van de Velde, C, Van Leeuwen, F, Liefers, G.J

Get full text

2005 EURECCA international comparison of treatment and survival in patients over the age of 80 years with stage III colon cancer by Bastiaannet, E, Breugom, A, Kiderlen, M, Iversen, L, Martling, A, Johansson, R, Van Eycken, E, Vandendael, T, Mroczkowski, P, Lippert, H, Rutten, H, Liefers, G.J, Lemmens, V, Boelens, P, Van de Velde, C

Get full text